XML 59 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
CASH FLOWS (USED IN) OPERATING ACTIVITIES    
Net loss $ (20,710,233) $ (9,284,877)
Adjustments to reconcile net loss to net cash (used in) operating activities    
Depreciation and amortization 17,875 883,995
Loss on disposal of fixed assets 49,278 6,056
Employee and director stock-based compensation - non-cash 1,613,854 $ 1,075,131
Stock warrant expense - non-cash $ 499,003
Deferred income taxes $ (384,128)
Impairment of goodwill $ 11,070,991
Loss on settlement of note payable - related parties $ 1,829,562
Loss on settlement of note payable 876,543
Changes in other assets and liabilities affecting cash flows used in operating activities    
Prepaid expenses, deposits and other assets $ 738,157 540,069
Accounts payable and accrued liabilities (303,989) (2,642,272)
Net cash (used in) operating activities (7,025,064) $ (7,099,921)
CASH FLOWS (USED IN) INVESTING ACTIVITIES    
Investment in Or-Genix (250,000)
Purchase of fixed assets (28,227)
Net cash (used in) investing activities $ (278,227)
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES    
Proceeds on notes payable $ 400,000
Payment of notes payable (1,540,000)
Proceeds from issuance of common stock 31,773,293
Net cash provided by financing activities   30,633,293
NET (DECREASE) INCREASE CASH AND CASH EQUIVALENTS $ (7,303,291) 23,533,372
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 21,883,887 254,964
CASH AND CASH EQUIVALENTS AT END OF PERIOD $ 14,580,596 23,788,336
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Acquisition of business in exchange for common stock 6,800,000
Conversion of accounts payable to notes payable related to Company's outside law firm 407,998
Issuance of shares of common stock and stock warrants as payment of notes payable - related parties 1,105,475
Issuance of shares of common stock and stock warrants as payment of notes payable 517,945
Issuance of shares of common stock and stock warrants as payment of accounts payable and accrued liabilities $ 1,361,404